May 16, 2012, Guangdong Rearl River Biotech Co., Ltd. was granted permission to launch initial public offering (IPO) of no more than 26.08 million A shares by China Securities Regulatory Commission ("CSRC").

Pearl River Bridge is primarily engaged in R&D, production and sale of condiment products including high salt liquid state soy source and compound seasonings.

Jingtian & Gongcheng acted as the issuer's lawyer.